GT BIOPHARMA INC (GTBP)

US36254L3087 - Common Stock

3.2  +0.39 (+13.88%)

After market: 3.06 -0.14 (-4.38%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
370K61K
-83.51%		27K
-55.74%		N/A
-100.00%		N/AN/AN/A20.474B64.804B
216.52%		97.626B
50.65%
EBITDA
YoY % growth
-790K-2.374M
-200.51%		-8.925M
-275.95%		N/A
-5.02%		N/A
-1,346.37%		N/A
84.11%		N/A
46.85%		N/A
40.94%		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-790K-2.396M
-203.29%		-8.927M
-272.58%		N/A
-5.01%		N/A
-1,346.23%		N/A
84.10%		N/A
46.85%		-6.222M
40.96%		-47.086M
-750.31%		-21.639M
63.04%		-14.224M
36.13%		-17.762M
-30.84%		-81.804M
-360.55%		-197.064M
-140.90%		-15.133M
92.32%		-15.618M
-3.21%		4.352M
127.86%		48.359M
1,011.19%		80.852M
67.19%
Operating Margin
-213.51%-3,927.87%-33,062.96%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.02%0.07%0.08%
EPS
YoY % growth
N/AN/AN/AN/AN/AN/AN/A-6.89-51.71
-1,063.40%		-20.04
74.91%		-6.12
71.19%		-6.93
-19.62%		-2.15
68.92%		-1.70
20.85%		-1.83
-7.19%		-1.10
39.66%		-0.26
76.85%		0.57
324.00%		N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-2.75
-83.60%		-2.75
-53.00%		-3.06
-39.73%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/A
EBIT
Q2Q % growth		-4.292M
-18.54%		-4.609M
-47.64%		-4.901M
-54.71%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 -1.64
-446.67%		-2.751.1140.45%
Q4 2023
Q2Q % growth		 -2.19
59.44%		-2.750.5620.48%
Q3 2023
Q2Q % growth		 -1.80
72.73%		-3.061.2641.18%
Q2 2023
Q2Q % growth		 -1.50
50.00%		-3.061.5650.98%
Q1 2023
Q2Q % growth		 -0.30
94.12%		-4.444.1493.24%
Q4 2022
Q2Q % growth		 -5.40
65.38%		-5.36-0.04-0.84%
Q3 2022
Q2Q % growth		 -6.60
-15.79%		-3.37-3.23-96.08%
Q2 2022
Q2Q % growth		 -3.00
23.08%		-5.362.3643.98%
Q1 2022
Q2Q % growth		 -5.10
90.71%		-9.494.3946.24%
Q4 2021
Q2Q % growth		 -15.60
84.66%		-6.32-9.28-146.68%
Q3 2021
Q2Q % growth		 -5.70 -6.430.7311.30%
Q2 2021
Q2Q % growth		 -3.90 -8.474.5753.93%
Q1 2021
Q2Q % growth		 -54.90 -7.50-47.40-632.29%
Q4 2020
Q2Q % growth		 -101.70 -1.38-100.32-7,285.62%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 37.13% 37.13%
RevenueN/A N/A N/A N/A